Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of MK-1064 in Healthy Young Males
NCT02549014Phase 1Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of mk-1064 in Insomnia (11 arms), sponsored by Merck & Co. Primary endpoints: Number of Participants Who Experienced One or More Adverse Events (AEs), Number of Participants Who Discontinued Study Due to an AE and 1 more. Started Jul 2009; status: completed.
02
Drugs
mk-1064
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02549014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549014.